AI-generated summary
This review discusses regenerative stem cell therapy as a possible future treatment for chronic obstructive pulmonary disease (COPD). The authors report that animal and human studies suggest stem and progenitor cells contribute to lung tissue repair, and they propose that stem cell administration or stimulating resident stem cells, including by photobiostimulation, may be a potential next-generation approach. The abstract does not report new clinical outcome data.
- Who or what was studied
- Patients with chronic obstructive pulmonary disease, based on animal and human studies discussed in the review
- Limits stated in the abstract
- The abstract describes the approach as a potential future therapy and reports no specific clinical outcome data or study counts.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on dovepress.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.